Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
USE OF CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS TO TREAT CANCER

No-Receipt date 2019-00694 - 15/02/2019
No-Filing date 20190800005 - 15/02/2019
No-Granting date 8000774 - 04/08/2020
No-EPO application date -
No-EPO granting date -
Gazette No-Publication date of application 6/2019 - 08/07/2019
Gazette No-Publication date of granted patent 8/2020 - 16/09/2020
Expiration date 28/08/2033
Kind of title Supplementary Protection Certificate for Medicinal Products
Legal status VALID
Priorities US201161502649 P29/06/2011/US
US421470 P09/12/2010/US
Active Substance of Supplementary Certificates TISAGENLECLEUCEL

IPC Classification

Related Documents

Related Titles
TypeMaster titleRelated title
[SPC] 20170402770

Owners
CodeFirstnameSurnameAddressTownZIPCountry
805828 THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA CENTER FOR TECHNOLOGY TRANSFER 3160 CHESTNUT STREET, SUITE 200PHILADELPHIA PA 19104-6283 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
1989949 JUNE, CARL, H.
1989950 LEVINE, BRUCE, L.
1989951 PORTER, DAVID, L.
1989952 KALOS, MICHAEL, D.
1989953 MILONE, MICHAEL C.

Representatives
CodeFirstnameSurnameAddressTownZip
3463MARIAATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"KOUMPARI 2ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
848EFANGELIAGIAZITZOGLOU - THOMAIDOUKOUMPARI 2ATHINA (ATTIKIS)10674 GREECE

Owners History

Title Instruments

Payments history
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015